- Admin
- #1
Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales for its coronavirus vaccine and top third-quarter expectations. Sales from the vaccine Comirnaty, meanwhile, tumbled 66% to $4.4 billion in the quarter, mainly due to changes in a European Commission supply agreement that pushed dose deliveries into the fourth quarter. Pfizer also announced Tuesday that a large international study found vaccinating moms-to-be was nearly 82% effective at preventing severe cases of RSV, the common but scary respiratory virus, in their babies’ most vulnerable first 90 days of life.